Consortium collaborator Pamala Jacobson, PharmD, FCCP, has been named a Distinguished Professor under the Pharmacy Scholars program. Prof. Jacobson's appointment grants her the "Distinguished Professor" title and $10,000 a year salary augmentation for a five-year period. The principal criteria for the award are the duration and significance of the person's contributions to the development of his/her discipline, and the impact of the person's scholarly endeavors on a national and international level. Prof. Jacobson is a renowned clinician, scientist, and national leader in clinical pharmacology. In her pharmacogenomics research program, she studies how to effectively use genetic and other biomarkers to improve drug efficacy and reduce toxicity. She has been a leader in the emerging field of precision medicine, serving as director of the University's Institute of Personalized Medicine and as one of four Principal Investigators of the Minnesota Precision Medicine Collaborative (MPMC), along with Consortium Chair Susan M. Wolf, JD; Ellen Demerath, PhD; and Kingshuk Sinha, PhD. You can view video of her commentary on Rex Chisholm's 2015 lecture, "Integrating Electronic Health Records and Genomics for Discovery and Implementation: The eMERGE Experience," which was sponsored by the Consortium, here.